요약정보
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.
- Resource Type
- Academic Journal
- Authors
- Herbst SA; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Vesterlund M; Department of Oncology-Pathology, Karolinska Institute and Science for Life Laboratory, Stockholm, Sweden.; Helmboldt AJ; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Jafari R; Department of Oncology-Pathology, Karolinska Institute and Science for Life Laboratory, Stockholm, Sweden.; Siavelis I; Department of Oncology-Pathology, Karolinska Institute and Science for Life Laboratory, Stockholm, Sweden.; Stahl M; Department of Oncology-Pathology, Karolinska Institute and Science for Life Laboratory, Stockholm, Sweden.; Schitter EC; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Liebers N; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Brinkmann BJ; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Czernilofsky F; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Roider T; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Bruch PM; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Iskar M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kittai A; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.; Huang Y; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.; Lu J; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Richter S; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Mermelekas G; Department of Oncology-Pathology, Karolinska Institute and Science for Life Laboratory, Stockholm, Sweden.; Umer HM; Department of Oncology-Pathology, Karolinska Institute and Science for Life Laboratory, Stockholm, Sweden.; Knoll M; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Kolb C; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Lenze A; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Cao X; Department of Oncology-Pathology, Karolinska Institute and Science for Life Laboratory, Stockholm, Sweden.; Österholm C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Wahnschaffe L; Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf (CIO ABCD), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Herling C; Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf (CIO ABCD), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Scheinost S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Ganzinger M; Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany.; Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Kriegsmann K; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Kriegsmann M; Institute of Pathology, University of Heidelberg, Heidelberg, Germany.; Anders S; Center for Molecular Biology of the University of Heidelberg (ZMBH), Heidelberg, Germany.; Zapatka M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Del Poeta G; Division of Hematology, University of Tor Vergata, Rome, Italy.; Zucchetto A; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Bomben R; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Dreger P; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; Woyach J; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.; Herling M; Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf (CIO ABCD), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Müller-Tidow C; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.; Stilgenbauer S; Department of Internal Medicine III, University of Ulm, Ulm, Germany.; Zenz T; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.; Huber W; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Tausch E; Department of Internal Medicine III, University of Ulm, Ulm, Germany.; Lehtiö J; Department of Oncology-Pathology, Karolinska Institute and Science for Life Laboratory, Stockholm, Sweden. Janne.Lehtio@ki.se.; Dietrich S; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany. sascha.dietrich@embl.de.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. sascha.dietrich@embl.de.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany. sascha.dietrich@embl.de.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany. sascha.dietrich@embl.de.; Department of Hematolgy, Oncology and Immunolgy, University Hospital of Düsseldorf, Düsseldorf, Germany. sascha.dietrich@embl.de.
- Source
- Publisher:
Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN:20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE - Subject
- Language
- English